Presentation is loading. Please wait.

Presentation is loading. Please wait.

Hirsutism Andrew Rodin 1st March 2016.

Similar presentations


Presentation on theme: "Hirsutism Andrew Rodin 1st March 2016."— Presentation transcript:

1 Hirsutism Andrew Rodin 1st March 2016

2 What is hirsutism? Development of androgen-dependent terminal body hair in a woman in places in which terminal hair is normally not found Terminal body hairs are thick, dark, pigmented hairs normally seen in men on the face, chest, abdomen and back

3 What is hirsutism? Differences in female body hair in different geographical populations A woman’s definition of hirsutism may differ depending on her ethnic origin and her subjective view of normal body hair distribution

4 What causes hirsutism? Increased production rate of androgens
Found in nearly all hirsute women Usually testosterone, but serum testosterone might not be above the normal range Increased conversion of testosterone to dihydrotestosterone in peripheral tissue, including hair follicles

5 Androgen biosynthesis in women

6 Causes of hirsutism Functional androgen excess disorders
Polycystic ovary syndrome (80%) Idiopathic hirsutism (10%) Specific identifiable disorders Non-classic congenital adrenal hyperplasia Thyroid dysfunction Hyperprolactinaemia Hyperandrogenism, insulin resistance and acanthosis nigricans (HAIR-AN) Virilising ovarian tumour Virilising adrenal tumour Hyperthecosis Cushing’s disease Acromegaly Drugs (danazol, testosterone, anabolic steroids, androgenic progestogens)

7 Idiopathic hirsutism Diagnosis of exclusion
Applies to women with hirsutism and no other clinical abnormalities No menstrual irregularity Serum androgens usually normal or only mildly elevated May be part of the PCOS spectrum

8 Polycystic ovary syndrome
Most common cause of androgen excess 6-8% women of reproductive age Evidence of hyperandrogenism and menstrual irregularity Rotterdam consensus criteria for diagnosis: 2 of the following: Oligo-/amenorrhoea Clinical or biochemical hyperandrogenism Characteristic appearance of ovaries by ultrasound

9 Polycystic ovary syndrome
Androgen excess usually becomes evident about the time of puberty or soon after Symptoms may develop or worsen in association with weight gain

10 PCOS pathogenesis

11 Congenital adrenal hyperplasia
Excess adrenal androgen production driven by ACTH is key feature of most forms of CAH Disorders may be recognised at birth or in early infancy Late onset or non-classical forms occur (21-hydroxlase deficiency most common) Prevalence of non-classical CAH among hirsute women varies from 1-15% Affected women present peripubertally with hirsutism and menstrual disturbance

12 Ovarian hyperthecosis
Characterised by severe hyperandrogenism and insulin resistance Seen primarily in post-menopausal women Women typically present with slowly progressive acne and hirsutism Likely to be virilised - clitoral enlargement, male pattern baldness, deepening of the voice, and a male habitus

13 Ovarian hyperthecosis
Severe form of PCOS Significantly increased stromal tissue with luteinized theca-like cells scattered throughout large sheets of fibroblast-like cells Hyperinsulinaemia - an important pathophysiological factor Increased risk of type 2 diabetes Risk of endometrial carcinoma

14 Androgen-secreting ovarian tumours
5% of all ovarian tumours (Sertoli-Leydig cell tumours, granulosa-theca cell tumours, hilus cell tumours) Hirsutism likely to start later and progress more rapidly than in PCOS Testosterone >5nmol/L and often much higher Affected women become virilised Tumours identified by transvaginal ultrasound

15 Adrenal tumours Rare cause of androgen excess
Some are adrenal adenomas that secrete mostly testosterone Most are carcinomas that often secrete cortisol and testosterone

16 Adrenal tumours Clinical picture is that of a woman who becomes virilised and has Cushing’s syndrome DHEAS produced almost exclusively by adrenal glands and high levels suggest adrenal pathology

17 Severe insulin resistance
Women with severe insulin resistance and hyperinsulinaemia often have hirsutism Hyperinsulinaemia causes ovarian hyperandrogenism through: Stimulation of theca cell receptors for IGF-1 Reduction of SHBG production by liver resulting in increased free testosterone

18 Clinical evaluation Most important information is the time course of symptoms and whether or not the woman is virilised Ascertain age at onset, rate of progression, and any change with any treatment or with fluctuations in weight

19 Assessment of hirsutism using the Ferriman and Gallwey score

20 Physical examination Hirsutism Body habitus
Other signs of androgen excess Acne, seborrhoea, temporal balding Virilisation Deep voice Android body shape Frontal balding Clitoromegaly (>10mm) Body habitus Shape, weight, BMI Breasts Galactorrhoea Skin Acanthosis nigricans Striae, thin skin, bruising BP Hypertension Abdomen and pelvis Mass lesions

21 Clinical pointers to a rare cause for hyperandrogenism
Abrupt onset Short duration Sudden, progressive worsening of hirsutism Onset in 3rd decade of life or later, rather than near puberty Symptoms or signs of virilisation

22 Initial investigations
The clinical picture will determine the initial strategy for investigations in women with hirsutism Clinical picture Initial investigations Long-standing hirsutism Serum testosterone Long-standing hirsutism and irregular menstrual cycles Serum testosterone, LH, FSH, prolactin Short history of hirsutism or progressive hirsutism Serum testosterone, DHEAS

23 Further investigations
Planned according to clinical suspicion and results of preliminary investigations Indication Next investigations Hirsutism + virilisation Testosterone >5nmol/L DHEAS normal Transvaginal ultrasound to look for ovarian tumour DHEAS elevated CT/MR adrenals to look for an adrenal tumour Early-onset hirsutism Short Synacthen test to measure 17- hydroxyprogesterone response or urine steroid profiling to test for congenital adrenal hyperplasia Clinical features of Cushing’s syndrome Low dose dexamethasone suppression test

24 Case history – Mrs SD Aged 66
Referred because of vitamin D deficiency and secondary hyperparathyroidism COPD diagnosed in 2013 Ex-heavy smoker Drugs: Symbicort, Tiotropium, omeprazole, co-dydramol, sertraline, simvastatin

25 Mrs SD Overweight – weight increased 2 stones
Impaired fasting glycaemia (6.4mmol/L) Bruising more easily and thinning of her hair over last 5 years Fatigue++ Menopause in 50’s 2 children, 3 miscarriages

26 Mrs SD - Examination 80.3kg, BP 145/88 mmHg
Appeared Cushingoid with central adiposity No deepening of voice Androgenic hair distribution over scalp No acanthosis nigricans Facial hirsutism and acne

27 Summary Incidental finding of hyperandrogenism with gradually worsening symptoms in a post-menopausal woman

28 Mrs SD - investigations
Testosterone 18nmol/L (<1.2) LH 19iu/L, FSH 45iu/L, oestradiol 155pmol/L DHEAS 1.8umol/L ( ) Prolactin 160mU/L (<800) Free T4 11.9pmol/L, TSH 0.53mU/L

29 Mrs SD - investigations
Ultrasound ovaries: no ovarian tumour CT abdomen: no adrenal tumour 1mg overnight dexamethasone suppression test: normal suppression of cortisol

30 Mrs SD - investigations
Long-acting GnRH agonist challenge Leuprorelin 3.75mg s/c Day 1: serum testosterone 25nmol/l Day 30: serum testosterone 0.9nmol/l Clinical diagnosis - ovarian hyperthecosis

31 Mrs SD - management Treated with Zoladex prior to surgery
Laparoscopic bilateral oophorectomy

32 Post-surgery follow-up
2 weeks post-surgery: No acne No further hair loss Weight loss of 3kg Lots more energy Feeling very well Serum testosterone 0.9mmol/L Fasting blood glucose 4.3mmol/L

33 Learning points Hirsutism is a common symptom
History crucial in assessment – particularly age at onset, progression, virilisation Testosterone >5nmol/L always requires further investigation Referral recommended if testosterone >3.5nmol/L In post-menopausal women, testosterone should be very low and hyperandrogenism should be investigated


Download ppt "Hirsutism Andrew Rodin 1st March 2016."

Similar presentations


Ads by Google